Literature DB >> 19666109

Regulation of the inducible nuclear dual-specificity phosphatase DUSP5 by ERK MAPK.

Anna Kucharska1, Linda K Rushworth, Christopher Staples, Nick A Morrice, Stephen M Keyse.   

Abstract

DUSP5 is an inducible, nuclear, dual-specificity phosphatase, which specifically interacts with and inactivates the ERK1/2 MAP kinases in mammalian cells. In addition, expression of DUSP5 causes nuclear translocation of ERK2 indicating that it may act as a nuclear anchor for the inactive kinase. Here we show that induction of DUSP5 mRNA and protein in response to growth factors is dependent on ERK1/2 activation and that the accumulation of DUSP5 protein is regulated by rapid proteasomal degradation. DUSP5 is phosphorylated by ERK1/2 both in vitro and in vivo on three sites (Thr321, Ser346 and Ser376) within its C-terminal domain. DUSP5 phosphorylation is absolutely dependent on the conserved kinase interaction motif (KIM) within the amino-terminal domain of DUSP5, indicating that the same protein-protein contacts are required for both the inactivation of ERK2 by DUSP5 and for DUSP5 to act as a substrate for this MAPK. Using a combination of pharmacological inhibitors and phospho-site mutants we can find no evidence that phosphorylation of DUSP5 by ERK2 significantly affects either the half-life of the DUSP5 protein or its ability to bind to, inactivate or anchor ERK2 in the nucleus. However, co-expression of ERK2 results in significant stabilisation of DUSP5, which is accompanied by reduced levels of DUSP5 ubiquitination. These changes are independent of ERK2 kinase activity but absolutely depend on the ability of ERK2 to bind to DUSP5. We conclude that DUSP5 is stabilised by complex formation with its physiological substrate and that this may reinforce its activity as both a phosphatase and nuclear anchor for ERK2.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19666109     DOI: 10.1016/j.cellsig.2009.07.015

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  55 in total

1.  Dependence of corneal epithelial cell proliferation on modulation of interactions between ERK1/2 and NKCC1.

Authors:  Zheng Wang; Victor N Bildin; Hua Yang; José E Capó-Aponte; Yuanquan Yang; Peter S Reinach
Journal:  Cell Physiol Biochem       Date:  2011-12-14

2.  Creating a pro-survival and anti-inflammatory phenotype by modulation of acetylation in models of hemorrhagic and septic shock.

Authors:  Yongqing Li; Hasan B Alam
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

3.  Pseudophosphatase STYX modulates cell-fate decisions and cell migration by spatiotemporal regulation of ERK1/2.

Authors:  Veronika Reiterer; Dirk Fey; Walter Kolch; Boris N Kholodenko; Hesso Farhan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-11       Impact factor: 11.205

4.  KRAS G13D sensitivity to neurofibromin-mediated GTP hydrolysis.

Authors:  Dana Rabara; Timothy H Tran; Srisathiyanarayanan Dharmaiah; Robert M Stephens; Frank McCormick; Dhirendra K Simanshu; Matthew Holderfield
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-14       Impact factor: 11.205

5.  EGF receptor and PKCδ kinase activate DNA damage-induced pro-survival and pro-apoptotic signaling via biphasic activation of ERK and MSK1 kinases.

Authors:  Angela M Ohm; Trisiani Affandi; Mary E Reyland
Journal:  J Biol Chem       Date:  2019-01-24       Impact factor: 5.157

6.  Knockout of Dual-Specificity Protein Phosphatase 5 Protects Against Hypertension-Induced Renal Injury.

Authors:  Chao Zhang; Xiaochen He; Sydney R Murphy; Huawei Zhang; Shaoxun Wang; Ying Ge; Wenjun Gao; Jan M Williams; Aron M Geurts; Richard J Roman; Fan Fan
Journal:  J Pharmacol Exp Ther       Date:  2019-05-22       Impact factor: 4.030

7.  Dynamic regulation of VEGF-inducible genes by an ERK/ERG/p300 transcriptional network.

Authors:  Jason E Fish; Manuel Cantu Gutierrez; Lan T Dang; Nadiya Khyzha; Zhiqi Chen; Shawn Veitch; Henry S Cheng; Melvin Khor; Lina Antounians; Makon-Sébastien Njock; Emilie Boudreau; Alexander M Herman; Alexander M Rhyner; Oscar E Ruiz; George T Eisenhoffer; Alejandra Medina-Rivera; Michael D Wilson; Joshua D Wythe
Journal:  Development       Date:  2017-05-23       Impact factor: 6.868

8.  Cordycepin promotes apoptosis by modulating the ERK-JNK signaling pathway via DUSP5 in renal cancer cells.

Authors:  Jung-Hoo Hwang; Jong Cheon Joo; Dae Joon Kim; Eunbi Jo; Hwa-Seung Yoo; Kyung-Bok Lee; Soo Jung Park; Ik-Soon Jang
Journal:  Am J Cancer Res       Date:  2016-08-01       Impact factor: 6.166

Review 9.  Extracellular-Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological Outcomes.

Authors:  Scott T Eblen
Journal:  Adv Cancer Res       Date:  2018-03-02       Impact factor: 6.242

10.  Growth arrest signaling of the Raf/MEK/ERK pathway in cancer.

Authors:  Jong-In Park
Journal:  Front Biol (Beijing)       Date:  2014-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.